Confirmatory study of PBT 2 in Huntington's disease.
Phase of Trial: Phase II
Latest Information Update: 10 Apr 2019
Price : $35 *
At a glance
- Drugs PBT 2 (Primary)
- Indications Huntington's disease
- Focus Adverse reactions; Therapeutic Use
- Sponsors Alterity Therapeutics
- 10 Apr 2019 According to an Alterity Therapeutics Limited media release, the company was formerly called as Prana Biotechnology Limited.
- 17 Apr 2014 New trial record